Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Post-traumatic Stress Disorder Stories

2014-03-20 12:29:18

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013 Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013" provides data on the Post-Traumatic Stress Disorder (PTSD) clinical trial scenario. This report provides...

2013-11-08 23:02:21

Health care providers should be prepared to offer services not only to those directly impacted by a traumatic event but also to those for whom such an event triggers reminders of a traumatic event experienced in the past, according to a study of 71 Boston-area veterans with a history of trauma and post-traumatic stress disorder (PTSD) before and after the Boston marathon bombing. The study, published in the Journal of Traumatic Stress, showed that there is considerable variability in how...

2013-11-05 11:55:59

Wars, earthquakes, major traffic accidents, and terrorist attacks may bring about profound spiritual pains, and even cause extreme fear and helplessness for people that have experienced or witnessed these unusual threats or disasters. This persistent and constant mental disorder caused by psychological trauma is termed post-traumatic stress disorder (PTSD). Can brain structural damage alter as symptoms improve? As PTSD progresses, brain structure inevitably changes, however, no PTSD symptoms...

2013-04-22 08:30:20

ROCKVILLE, Md., April 22, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it has received approval from the Food and Drug Administration (FDA) to begin dosing the third and final cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD). NSI-189, the lead compound in Neuralstem's neurogenic small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, a...

2012-12-19 05:03:34

Winter break from school is a time for children to spend with their family after this tragic week. Time for us to all pray for the new angels above and help the survivors through Post Traumatic Stress Disorder. Dr. Bonnie suggests "Family play therapy is a way to help children through PTSD as play is for children as conversation is to adults." New York, NY (PRWEB) December 19, 2012 Dr. Bonnie happily shares, “Children are safe and snuggly in their cocoon, similar to in the womb, when...

2012-12-03 16:48:45

Gene-environment interaction causes lifelong dysregulation of stress hormones Abused children are at high risk of anxiety and mood disorders, as traumatic experience induces lasting changes to their gene regulation. Scientists from the Max Planck Institute of Psychiatry in Munich have now documented for the first time that genetic variants of the FKBP5 gene can influence epigenetic alterations in this gene induced by early trauma. In individuals with a genetic predisposition, trauma causes...

2012-10-19 04:01:05

Judith A., Swack, Ph.D., president of Healing from the Body Level Up, details successful treatment of post-traumatic stress disorder in just a few sessions in a paper published in the International Journal of Healing & Caring - Online.. (PRWEB) October 18, 2012 The September issue of the International Journal of Healing & Caring — Online has published a major paper outlining effective treatment of post-traumatic stress disorder in both civilians and veterans. The paper,...

2012-10-17 07:27:57

ROCKVILLE, Md., Oct. 17, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD). NSI-189, the lead compound in Neuralstem's neurogenic small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, a region of the brain believed to be implicated in MDD, as well as other...

2012-06-25 02:26:56

ROCKVILLE, Md., June 25, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD). NSI-189, the lead compound in Neuralstem's small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, a region of the brain believed to be implicated in MDD as well as other diseases and...

2012-03-19 15:54:28

Book sheds new light on post-traumatic stress disorder and its often devastating aftermath A new book by a University of New Hampshire researcher and Vietnam-era disabled veteran sheds new light on the long-term psychological trauma experienced by the coalition force in recent wars in the Gulf and Balkans that, when left untreated, can have deadly consequences. In his new book "War Trauma and its Aftermath: An International Perspective on the Balkan and Gulf Wars" (University Press of...